1. Home
  2. USAC vs LQDA Comparison

USAC vs LQDA Comparison

Compare USAC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USAC

USA Compression Partners LP Common Units Representing Limited Partner Interests

HOLD

Current Price

$25.07

Market Cap

2.9B

Sector

Utilities

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$30.73

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAC
LQDA
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
USAC
LQDA
Price
$25.07
$30.73
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$25.00
$37.40
AVG Volume (30 Days)
256.5K
2.2M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
8.44%
N/A
EPS Growth
43.67
N/A
EPS
0.81
N/A
Revenue
$991,507,000.00
$69,216,000.00
Revenue This Year
$7.32
$424.31
Revenue Next Year
$4.51
$359.32
P/E Ratio
$30.77
N/A
Revenue Growth
6.66
343.41
52 Week Low
$21.53
$10.37
52 Week High
$30.10
$32.80

Technical Indicators

Market Signals
Indicator
USAC
LQDA
Relative Strength Index (RSI) 65.90 60.95
Support Level $23.40 $27.76
Resistance Level $26.07 $32.80
Average True Range (ATR) 0.72 1.78
MACD 0.19 0.20
Stochastic Oscillator 70.28 68.59

Price Performance

Historical Comparison
USAC
LQDA

About USAC USA Compression Partners LP Common Units Representing Limited Partner Interests

USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: